BVAN08 enhances radiosensitivity via downregulation of DNA-PKcs towards hepatic tumor xenograft

Bo Zhang,Lantao Liu,Sai Hu,Zi-jian Yu,Dafei Xie,P. Zhou

Published 2020 in Unknown venue

ABSTRACT

Abstract Objective To study the effects of the novel vanillin derivative BVAN08 on the radiosensitivity of hepatic cancer cells for the purpose of providing evidence for its potential use as a potential radiosensitive drug. Methods Hepatic cancer Huh-7 ​cells labeled with luciferase were used to investigate the radiosensitivity induced by BVAN08 in vivo. Colony formation assays and flow cytometry were used to measure the apoptosis and radiosensitivity of Huh-7 ​cells in vitro produced by BVAN08. Histology and immunohistochemistry were used to evaluate the toxicity of BVAN08 in vivo. Results BVAN08 induced apoptosis and cell cycle arrest of Huh-7 ​cells in a time-dependent manner. Moreover, BVAN08 combined with radiation increased the sensitivity of Huh-7 ​cells to γ-ray radiation and significantly inhibited tumor growth in vivo. The tumor inhibition rates of the BVAN08 treatment group, irradiation treatment group, and combined therapy group were 58%, 38%, and 85%, respectively. The DNA-PKcs expression in tumor tissues of the BVAN08 treatment group was lower than that of the control group (P ​ Conclusions As a natural food additive derivative, BVAN08 possesses the potential to be used as an effective anti-cancer drug to increase cell sensitivity to radiotherapy.

PUBLICATION RECORD

CITATION MAP

EXTRACTION MAP

CLAIMS

  • No claims are published for this paper.

CONCEPTS

  • No concepts are published for this paper.

REFERENCES

Showing 1-28 of 28 references · Page 1 of 1

CITED BY

  • No citing papers are available for this paper.

Showing 0-0 of 0 citing papers · Page 1 of 1